Chiltern expands presence in India

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/uomas_Lehtinen)
(Image: iStock/uomas_Lehtinen)

Related tags: Executive vice president, Contract research organization, Management occupations

Chiltern has opened a new process and technology center in Bangalore, India to further support its analytics, risk-based optimization, biometrics, and pharmacovigilance capabilities.

The company’s first office in India opened more than a decade ago – with five programmers. With the latest expansion, the contract research organization (CRO) can support more than 600 employees throughout its offices in India.

Our continued growth and our work to further enhance our global data capabilities based on the needs of our clients led to this further expansion in India​,” Mark Penniston, executive vice president, clinical analytics, and general manager at Chiltern, told us.

Specifically, he cited the increasing global demand, “particularly with the complexity of studies today​.” 

“[The new center] will further expand our depth and breadth in our data and analysis teams’ capabilities while increasing our existing 24-hour global presence​,” Penniston added.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars